van Ruiten CC, Veltman DJ, Schrantee A, van Bloemendaal L, Barkhof F, Kramer MHH et al (2022) Effects of dapagliflozin and combination therapy with exenatide on food-cue induced brain activation in patients With type 2 diabetes
Profiling COVID-19 vaccine adverse events by statistical and ontological analysis of VAERS case reports
As GLP-1 medications continue to grow in popularity for both diabetes management and weight loss, patients are often faced with a key decision: should you take your medication as a weekly injection or a daily pill
At higher supplement doses (5002000 mcg), only about 12% is absorbed passively, but this is still effective for treating a deficiency
Our providers will administer injections safely in-office
An update on liposomes in drug delivery: a patent review (2014-2018)